Quantbot Technologies LP Immunovant, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$18.55 - $39.96 $124,285 - $267,732	6,700 New	6,700 $257,000
Q1 2023 May 12, 2023	SELL	$15.27 - $19.72 $178,491 - $230,507	-11,689 Reduced 44.74%	14,437 $223,000
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $172,170 - $463,736	26,126 New	26,126 $463,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $82,037 - $142,188	-16,213 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.33 - $9.32 $118,841 - $151,105	16,213 New	16,213 $138,000

211

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.